Latest filing published 19 Sept 2017 for BioSyent Inc., €5,183.
Milt Wakefield is a declared insider of BioSyent Inc., with filings sourced from SEDI. Between 12 February 2016 and 18 September 2017, the trades on record add up to 18 filings.
On the market, this insider has only sold: 13 sales, €164k in total. Other entries cover 4 option exercises. Since January 2017: no purchases and 6 sales on the market.
The record was last updated on 19 September 2017 with an option exercise (€3,008) in BioSyent Inc. Publication is fast: at least half of the trades appear on SEDI on the same day. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations